Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma.

  • Authors : Haertle L; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.; Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Complutense University Madrid, Madrid, Spain.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/metabolism

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jan 04; Vol. 29 (1), pp. 279-288.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265

تفاصيل العنوان

×
Academic Journal

Cereblon enhancer methylation and IMiD resistance in multiple myeloma.

  • Authors : Haertle L; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.; Institute of Human Genetics, Julius Maximilian University of Würzburg, Würzburg, Germany.

Subjects: Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/*genetics ; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use ; Immunomodulating Agents/Immunomodulating Agents/Immunomodulating Agents/*therapeutic use

  • Source: Blood [Blood] 2021 Nov 04; Vol. 138 (18), pp. 1721-1726.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

تفاصيل العنوان

×
Report

Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.

  • Authors : Martinez-Lopez J; Hematology Department, Hospital 12 de Octubre i+12, CNIO, Complutense University, Madrid, Spain. .; Department of Medicine, Division of Hematology-Oncology, University of California San Francisco, San Francisco, USA. .

Subjects: Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*diagnosis ; Neoplasm, Residual/Neoplasm, Residual/Neoplasm, Residual/*diagnosis; Clinical Decision-Making

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2021 Aug 17; Vol. 14 (1), pp. 126. Date of Electronic Publication: 2021 Aug 17.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

×
Report

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing.

  • Authors : Ruiz-Heredia Y; Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain.; Sánchez-Vega B

Subjects: Databases, Nucleic Acid*; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*genetics ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*mortality

  • Source: Haematologica [Haematologica] 2018 Nov; Vol. 103 (11), pp. e544-e548. Date of Electronic Publication: 2018 Jun 28.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; High-Throughput Nucleotide Sequencing/High-Throughput Nucleotide Sequencing/High-Throughput Nucleotide Sequencing/*methods ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy

  • Source: Leukemia [Leukemia] 2017 Jun; Vol. 31 (6), pp. 1446-1449. Date of Electronic Publication: 2017 Feb 17.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-6 of  6 نتائج ل ""Ruiz-Heredia Y.""